Skip to main content
Top
Published in: Respiratory Research 1/2010

Open Access 01-12-2010 | Research

Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients

Authors: Richard A Urbanowicz, Jonathan R Lamb, Ian Todd, Jonathan M Corne, Lucy C Fairclough

Published in: Respiratory Research | Issue 1/2010

Login to get access

Abstract

Background

We have previously shown that NK (CD56+CD3-) and NKT-like (CD56+CD3+) cells are reduced in both numbers and cytotoxicity in peripheral blood. The aim of the present study was to investigate their numbers and function within induced sputum.

Methods

Induced sputum cell numbers and intracellular granzyme B and perforin were analysed by flow cytometry. Immunomagnetically selected CD56+ cells (NK and NKT-like cells) were used in an LDH release assay to determine cytotoxicity.

Results

The proportion of NK cells and NKT-like cells in smokers with COPD (COPD subjects) was significantly higher (12.7% and 3%, respectively) than in healthy smokers (smokers) (5.7%, p < 0.01; 1%, p < 0.001) and non-smoking healthy subjects (HNS) (4.2%, p < 0.001; 0.8%, p < 0.01). The proportions of NK cells and NKT-like cells expressing both perforin and granzyme B were also significantly higher in COPD subjects compared to smokers and HNS. CD56+ cells from COPD subjects were significantly more cytotoxic (1414 biological lytic activity) than those from smokers (142.5; p < 0.01) and HNS (3.8; p < 0.001) and were inversely correlated to FEV1. (r = -0.75; p = 0.0098).

Conclusion

We have shown an increased proportion of NK and NKT-like cells in the induced sputum of COPD subjects and have demonstrated that these cells are significantly more cytotoxic in COPD subjects than smokers and HNS.
Literature
1.
go back to reference Molfino NA, Jeffery PK: Chronic obstructive pulmonary disease: histopathology, inflammation and potential therapies. Pulm Pharmacol Ther 2007,20(5):462–472.CrossRefPubMed Molfino NA, Jeffery PK: Chronic obstructive pulmonary disease: histopathology, inflammation and potential therapies. Pulm Pharmacol Ther 2007,20(5):462–472.CrossRefPubMed
3.
go back to reference Cosio MG, Guerassimov A: Chronic obstructive pulmonary disease. Inflammation of small airways and lung parenchyma. Am J Respir Crit Care Med 1999,160(5 Pt 2):S21–25.CrossRefPubMed Cosio MG, Guerassimov A: Chronic obstructive pulmonary disease. Inflammation of small airways and lung parenchyma. Am J Respir Crit Care Med 1999,160(5 Pt 2):S21–25.CrossRefPubMed
4.
go back to reference Keatings VM, Collins PD, Scott DM, Barnes PJ: Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996,153(2):530–534.CrossRefPubMed Keatings VM, Collins PD, Scott DM, Barnes PJ: Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996,153(2):530–534.CrossRefPubMed
5.
go back to reference Fairclough L, Urbanowicz RA, Corne J, Lamb JR: Killer cells in chronic obstructive pulmonary disease. Clin Sci (Lond) 2008,114(8):533–541.CrossRef Fairclough L, Urbanowicz RA, Corne J, Lamb JR: Killer cells in chronic obstructive pulmonary disease. Clin Sci (Lond) 2008,114(8):533–541.CrossRef
6.
go back to reference Berke G: The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu Rev Immunol 1994, 12:735–773.CrossRefPubMed Berke G: The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu Rev Immunol 1994, 12:735–773.CrossRefPubMed
7.
go back to reference Hashimoto S, Kobayashi A, Kooguchi K, Kitamura Y, Onodera H, Nakajima H: Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med 2000,161(1):237–243.CrossRefPubMed Hashimoto S, Kobayashi A, Kooguchi K, Kitamura Y, Onodera H, Nakajima H: Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med 2000,161(1):237–243.CrossRefPubMed
8.
go back to reference Rutgers SR, Postma DS, ten Hacken NH, Kauffman HF, van Der Mark TW, Koeter GH, Timens W: Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000,55(1):12–18.CrossRefPubMedPubMedCentral Rutgers SR, Postma DS, ten Hacken NH, Kauffman HF, van Der Mark TW, Koeter GH, Timens W: Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000,55(1):12–18.CrossRefPubMedPubMedCentral
9.
go back to reference Hodge S, Hodge G, Nairn J, Holmes M, Reynolds PN: Increased airway granzyme b and perforin in current and ex-smoking COPD subjects. Copd 2006,3(4):179–187.CrossRefPubMed Hodge S, Hodge G, Nairn J, Holmes M, Reynolds PN: Increased airway granzyme b and perforin in current and ex-smoking COPD subjects. Copd 2006,3(4):179–187.CrossRefPubMed
10.
go back to reference Costabel U, Maier K, Teschler H, Wang YM: Local immune components in chronic obstructive pulmonary disease. Respiration 1992,59(Suppl 1):17–19.PubMed Costabel U, Maier K, Teschler H, Wang YM: Local immune components in chronic obstructive pulmonary disease. Respiration 1992,59(Suppl 1):17–19.PubMed
11.
go back to reference Chrysofakis G, Tzanakis N, Kyriakoy D, Tsoumakidou M, Tsiligianni I, Klimathianaki M, Siafakas NM: Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest 2004,125(1):71–76.CrossRefPubMed Chrysofakis G, Tzanakis N, Kyriakoy D, Tsoumakidou M, Tsiligianni I, Klimathianaki M, Siafakas NM: Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest 2004,125(1):71–76.CrossRefPubMed
12.
13.
go back to reference Rutgers SR, Timens W, Kaufmann HF, van der Mark TW, Koeter GH, Postma DS: Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J 2000,15(1):109–115.CrossRefPubMed Rutgers SR, Timens W, Kaufmann HF, van der Mark TW, Koeter GH, Postma DS: Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J 2000,15(1):109–115.CrossRefPubMed
14.
go back to reference Rufino R, Costa CH, Souza HS, Madi K, Silva JR: Induced sputum and peripheral blood cell profile in chronic obstructive pulmonary disease. J Bras Pneumol 2007,33(5):510–518.PubMed Rufino R, Costa CH, Souza HS, Madi K, Silva JR: Induced sputum and peripheral blood cell profile in chronic obstructive pulmonary disease. J Bras Pneumol 2007,33(5):510–518.PubMed
15.
go back to reference Tzanakis N, Chrysofakis G, Tsoumakidou M, Kyriakou D, Tsiligianni J, Bouros D, Siafakas NM: Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease. Respir Med 2004,98(1):57–65.CrossRefPubMed Tzanakis N, Chrysofakis G, Tsoumakidou M, Kyriakou D, Tsiligianni J, Bouros D, Siafakas NM: Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease. Respir Med 2004,98(1):57–65.CrossRefPubMed
16.
go back to reference Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, et al.: The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004,350(26):2645–2653.CrossRefPubMed Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, et al.: The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004,350(26):2645–2653.CrossRefPubMed
17.
go back to reference Bosken CH, Hards J, Gatter K, Hogg JC: Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry. Am Rev Respir Dis 1992,145(4 Pt 1):911–917.CrossRefPubMed Bosken CH, Hards J, Gatter K, Hogg JC: Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry. Am Rev Respir Dis 1992,145(4 Pt 1):911–917.CrossRefPubMed
18.
go back to reference van der Strate BW, Postma DS, Brandsma CA, Melgert BN, Luinge MA, Geerlings M, Hylkema MN, van den Berg A, Timens W, Kerstjens HA: Cigarette smoke-induced emphysema: A role for the B cell? Am J Respir Crit Care Med 2006,173(7):751–758.CrossRefPubMed van der Strate BW, Postma DS, Brandsma CA, Melgert BN, Luinge MA, Geerlings M, Hylkema MN, van den Berg A, Timens W, Kerstjens HA: Cigarette smoke-induced emphysema: A role for the B cell? Am J Respir Crit Care Med 2006,173(7):751–758.CrossRefPubMed
19.
go back to reference Sallusto F, Geginat J, Lanzavecchia A: Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004, 22:745–763.CrossRefPubMed Sallusto F, Geginat J, Lanzavecchia A: Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004, 22:745–763.CrossRefPubMed
20.
go back to reference Dalbeth N, Gundle R, Davies RJ, Lee YC, McMichael AJ, Callan MF: CD56 bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol 2004,173(10):6418–6426.CrossRefPubMed Dalbeth N, Gundle R, Davies RJ, Lee YC, McMichael AJ, Callan MF: CD56 bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol 2004,173(10):6418–6426.CrossRefPubMed
21.
go back to reference Takahashi T, Chiba S, Nieda M, Azuma T, Ishihara S, Shibata Y, Juji T, Hirai H: Cutting edge: analysis of human V alpha 24+CD8+ NK T cells activated by alpha-galactosylceramide-pulsed monocyte-derived dendritic cells. J Immunol 2002,168(7):3140–3144.CrossRefPubMed Takahashi T, Chiba S, Nieda M, Azuma T, Ishihara S, Shibata Y, Juji T, Hirai H: Cutting edge: analysis of human V alpha 24+CD8+ NK T cells activated by alpha-galactosylceramide-pulsed monocyte-derived dendritic cells. J Immunol 2002,168(7):3140–3144.CrossRefPubMed
22.
go back to reference Gumperz JE, Miyake S, Yamamura T, Brenner MB: Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1 d tetramer staining. J Exp Med 2002,195(5):625–636.CrossRefPubMedPubMedCentral Gumperz JE, Miyake S, Yamamura T, Brenner MB: Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1 d tetramer staining. J Exp Med 2002,195(5):625–636.CrossRefPubMedPubMedCentral
23.
go back to reference Kim CH, Butcher EC, Johnston B: Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol 2002,23(11):516–519.CrossRefPubMed Kim CH, Butcher EC, Johnston B: Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol 2002,23(11):516–519.CrossRefPubMed
24.
25.
go back to reference Tzortzaki EG, Siafakas NM: A hypothesis for the initiation of COPD. Eur Respir J 2009,34(2):310–315.CrossRefPubMed Tzortzaki EG, Siafakas NM: A hypothesis for the initiation of COPD. Eur Respir J 2009,34(2):310–315.CrossRefPubMed
26.
go back to reference Saetta M, Mariani M, Panina-Bordignon P, Turato G, Buonsanti C, Baraldo S, Bellettato CM, Papi A, Corbetta L, Zuin R, et al.: Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002,165(10):1404–1409.CrossRefPubMed Saetta M, Mariani M, Panina-Bordignon P, Turato G, Buonsanti C, Baraldo S, Bellettato CM, Papi A, Corbetta L, Zuin R, et al.: Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002,165(10):1404–1409.CrossRefPubMed
27.
go back to reference Costa C, Rufino R, Traves SL, Lapa ESJR, Barnes PJ, Donnelly LE: CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. Chest 2008,133(1):26–33.CrossRefPubMed Costa C, Rufino R, Traves SL, Lapa ESJR, Barnes PJ, Donnelly LE: CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. Chest 2008,133(1):26–33.CrossRefPubMed
28.
go back to reference Crapo RO, Jensen RL, Hargreave FE: Airway inflammation in COPD: physiological outcome measures and induced sputum. Eur Respir J Suppl 2003, 41:19s-28s.CrossRefPubMed Crapo RO, Jensen RL, Hargreave FE: Airway inflammation in COPD: physiological outcome measures and induced sputum. Eur Respir J Suppl 2003, 41:19s-28s.CrossRefPubMed
29.
30.
go back to reference Turato G, Di Stefano A, Maestrelli P, Mapp CE, Ruggieri MP, Roggeri A, Fabbri LM, Saetta M: Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Crit Care Med 1995,152(4 Pt 1):1262–1267.CrossRefPubMed Turato G, Di Stefano A, Maestrelli P, Mapp CE, Ruggieri MP, Roggeri A, Fabbri LM, Saetta M: Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Crit Care Med 1995,152(4 Pt 1):1262–1267.CrossRefPubMed
31.
go back to reference Gamble E, Grootendorst DC, Hattotuwa K, O'Shaughnessy T, Ram FS, Qiu Y, Zhu J, Vignola AM, Kroegel C, Morell F, et al.: Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis. Eur Respir J 2007,30(3):467–471.CrossRefPubMed Gamble E, Grootendorst DC, Hattotuwa K, O'Shaughnessy T, Ram FS, Qiu Y, Zhu J, Vignola AM, Kroegel C, Morell F, et al.: Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis. Eur Respir J 2007,30(3):467–471.CrossRefPubMed
32.
go back to reference Loppow D, Bottcher M, Gercken G, Magnussen H, Jorres RA: Flow cytometric analysis of the effect of dithiothreitol on leukocyte surface markers. Eur Respir J 2000,16(2):324–329.CrossRefPubMed Loppow D, Bottcher M, Gercken G, Magnussen H, Jorres RA: Flow cytometric analysis of the effect of dithiothreitol on leukocyte surface markers. Eur Respir J 2000,16(2):324–329.CrossRefPubMed
33.
go back to reference Tsoumakidou M, Tzanakis N, Chrysofakis G, Kyriakou D, Siafakas NM: Changes in sputum T-lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease. Respir Med 2005,99(5):572–579.CrossRefPubMed Tsoumakidou M, Tzanakis N, Chrysofakis G, Kyriakou D, Siafakas NM: Changes in sputum T-lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease. Respir Med 2005,99(5):572–579.CrossRefPubMed
Metadata
Title
Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients
Authors
Richard A Urbanowicz
Jonathan R Lamb
Ian Todd
Jonathan M Corne
Lucy C Fairclough
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2010
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-11-76

Other articles of this Issue 1/2010

Respiratory Research 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.